Abbott Laboratories Detailed Financials

Full historical quarterly statements

Metric2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Total Revenue11.16B11.46B11.37B11.14B10.36B10.97B10.63B10.38B
Cost of Goods Sold4.88B4.92B5.03B4.85B4.91B5.38B5.21B5.07B
Gross Profit6.28B6.54B6.34B6.29B5.44B5.60B5.43B5.30B
R&D Expenses756.0M735.0M785.0M732.0M703.0M728.0M713.0M697.0M
Operating Expenses4.44B4.29B4.31B4.24B3.76B3.61B3.61B3.62B
Operating Income1.84B2.25B2.06B2.05B1.69B1.99B1.82B1.69B
Other Income / Gains-393.0M107.0M123.0M98.0M90.0M40.0M122.0M-79.0M
Net Income1.08B1.78B1.64B1.78B1.32B9.23B1.65B1.30B
EPS (Diluted)0.621.020.941.020.7585.330.950.75
Reported CurrencyUSDUSDUSDUSDUSDUSDUSDUSD
Gross Profit Ratio0.5630.570.5570.5640.5260.510.510.511
General And Administrative Expenses03.13B000000
Selling And Marketing Expenses00000000
Selling General And Administrative Expenses3.26B3.13B3.10B3.09B3.05B2.88B2.90B2.92B
Other Expenses422.0M422.0M420.0M411.0M0000
Cost And Expenses9.32B9.21B9.31B9.09B8.67B8.98B8.82B8.69B
Interest Income0077.0M71.0M82.0M91.0M91.0M82.0M
Interest Expense68.0M42.0M44.0M121.0M134.0M152.0M166.0M168.0M
Depreciation And Amortization0422.0M791.0M777.0M756.0M807.0M801.0M805.0M
Ebitda1.84B2.82B3.09B3.05B2.67B2.99B2.91B2.58B
Ebitdaratio0.1650.2460.2720.2740.2580.2720.2730.249
Operating Income Ratio0.1650.1960.1810.1840.1630.1810.1710.162
Income Before Tax1.45B2.36B2.18B2.15B1.78B2.03B1.94B1.61B
Income Before Tax Ratio0.130.2060.1920.1930.1720.1850.1820.155
Income Tax Expense372.0M582.0M536.0M371.0M453.0M-7.20B294.0M305.0M
Net Income Ratio0.0960.1550.1450.160.1280.8410.1550.125
Epsdiluted0.621.020.941.010.7585.270.940.74
Weighted Average Shs Out1.75B1.75B1.75B1.74B1.75B1.73B1.73B1.73B
Weighted Average Shs Out Dil1.75B1.75B1.75B1.75B1.75B1.75B1.75B1.75B